These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8985663)

  • 41. Beta-lactam susceptibility of Haemophilus influenzae strains showing reduced susceptibility to cefuroxime.
    James PA; Hossain FK; Lewis DA; White DG
    J Antimicrob Chemother; 1993 Aug; 32(2):239-46. PubMed ID: 8226426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin.
    Fuchs PC; Barry AL; Brown SD
    J Clin Microbiol; 2001 Jan; 39(1):43-6. PubMed ID: 11136745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro selection of resistance in haemophilus influenzae by 4 quinolones and 5 beta-lactams.
    Clark C; Kosowska K; Bozdogan B; Credito K; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Diagn Microbiol Infect Dis; 2004 May; 49(1):31-6. PubMed ID: 15135497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolates of β-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem.
    García-Cobos S; Arroyo M; Pérez-Vázquez M; Aracil B; Lara N; Oteo J; Cercenado E; Campos J
    J Antimicrob Chemother; 2014 Jan; 69(1):111-6. PubMed ID: 23943391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haemophilus influenzae ATCC 49766, an alternative quality control strain for monitoring broth microdilution susceptibility tests with selected beta-lactams.
    Barry AL; Jorgensen JH; Hardy DJ; Allen SD; Baker CN
    J Clin Microbiol; 1992 Aug; 30(8):2033-7. PubMed ID: 1500511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of inoculum size on Haemophilus influenzae type b susceptibility to new and conventional antibiotics.
    Laferriere C; Marks MI; Welch DF
    Antimicrob Agents Chemother; 1983 Aug; 24(2):287-9. PubMed ID: 6605716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Serotype distribution and drug resistance of
    Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
    Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
    [No Abstract]   [Full Text] [Related]  

  • 48. Serotypes, antimicrobial susceptibility, and beta-lactam resistance mechanisms of clinical Haemophilus influenzae isolates from Bulgaria in a pre-vaccination period.
    Setchanova LP; Kostyanev T; Markovska R; Miloshev G; Mitov IG
    Scand J Infect Dis; 2013 Feb; 45(2):81-7. PubMed ID: 22992181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.
    López-Cerero L; Picón E; Morillo C; Hernández JR; Docobo F; Pachón J; Rodríguez-Baño J; Pascual A
    Clin Microbiol Infect; 2010 Feb; 16(2):132-6. PubMed ID: 19614715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Susceptibility of clinically significant Haemophilus influenzae strains to oral antimicrobial agents used in Saudi Arabia.
    Shibl AM; Gaillot O
    Chemotherapy; 1994; 40(6):399-403. PubMed ID: 7842823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibiotic resistance in respiratory tract isolates of Haemophilus influenzae and Moraxella catarrhalis collected from across Canada in 1997-1998.
    Zhanel GG; Karlowsky JA; Low DE; Hoban DJ
    J Antimicrob Chemother; 2000 May; 45(5):655-62. PubMed ID: 10797089
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Multicenter-evaluation of optimal cell density to determine antimicrobial susceptibility for Haemophilus influenzae by the automated RAISUS system when the early-harvested bacterial cells were used].
    Matsukawa Y; Miyabe T; Sawamura H; Higa M; Yamane N; Urasoko A; Endo R
    Rinsho Byori; 2007 Jul; 55(7):611-8. PubMed ID: 17718056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic resistance among recent clinical isolates of Haemophilus influenzae in Japanese children.
    Ohkusu K; Nakamura A; Sawada K
    Diagn Microbiol Infect Dis; 2000 Apr; 36(4):249-54. PubMed ID: 10764967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel mechanisms of resistance to β-lactam antibiotics in Haemophilus parainfluenzae: β-lactamase-negative ampicillin resistance and inhibitor-resistant TEM β-lactamases.
    García-Cobos S; Arroyo M; Campos J; Pérez-Vázquez M; Aracil B; Cercenado E; Orden B; Lara N; Oteo J
    J Antimicrob Chemother; 2013 May; 68(5):1054-9. PubMed ID: 23335113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
    Tremblay LD; L'Ecuyer J; Provencher P; Bergeron MG
    CMAJ; 1990 Nov; 143(9):895-901. PubMed ID: 2224717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro study of the post-antibiotic effect and the bactericidal activity of Cefditoren and ten other oral antimicrobial agents against upper and lower respiratory tract pathogens.
    Dubois J; St-Pierre C
    Diagn Microbiol Infect Dis; 2000 Jul; 37(3):187-93. PubMed ID: 10904192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.
    Torrico M; Aguilar L; González N; Giménez MJ; Echeverría O; Cafini F; Sevillano D; Alou L; Coronel P; Prieto J
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3699-706. PubMed ID: 17664320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999-2007.
    Morrissey I; Maher K; Williams L; Shackcloth J; Felmingham D; Reynolds R;
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii97-103. PubMed ID: 18819984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.
    Thornsberry C; Ogilvie P; Kahn J; Mauriz Y
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):249-57. PubMed ID: 9458982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of Etest, M.I.C.Evaluator strips and CLSI broth microdilution for determining {beta}-lactam antimicrobial susceptibility in Haemophilus influenzae.
    Tristram SG
    J Antimicrob Chemother; 2008 Dec; 62(6):1464-6. PubMed ID: 18772157
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.